Mobic (Meloxicam)

• Mobic is an NSAID that reduces inflammation and pain in several musculoskeletal disorders.
• Osteoarthritis: alleviates joint pain and swelling, improving function.
• Rheumatoid arthritis: decreases synovial inflammation and joint damage progression.
• Juvenile rheumatoid arthritis: controls pain and inflammation in pediatric patients.
• Ankylosing spondylitis: reduces spinal stiffness and discomfort.
• Acute pain: provides rapid relief of moderate to severe pain from injury or surgery.

• Meloxicam preferentially inhibits the cyclooxygenase‑2 (COX‑2) enzyme, which limits the conversion of arachidonic acid to prostaglandins. By reducing prostaglandin synthesis, it diminishes inflammatory mediators at sites of tissue injury, leading to decreased pain, swelling, and fever without markedly affecting COX‑1 mediated gastric protection at therapeutic doses.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects

• Gastro‑intestinal discomfort, including dyspepsia or nausea.
• Headache or dizziness.
• Mild peripheral edema.
• Elevated blood pressure.
• Skin rash or pruritus.

Serious or Rare Side Effects

• Gastro‑intestinal ulceration or bleeding.
• Cardiovascular events such as myocardial infarction or stroke.
• Severe hepatic enzyme elevation or hepatitis.
• Acute renal failure or worsening of chronic kidney disease.
• Life‑threatening skin reactions (e.g., Stevens‑Johnson syndrome).

• Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.
• Assess gastrointestinal risk: avoid in patients with active ulcers or severe GI disease.
• Monitor cardiovascular status: use caution in patients with known heart disease or hypertension.
• Evaluate renal function: adjust or discontinue if renal impairment develops.
• Use the lowest effective dose: limit duration to the shortest period needed for symptom control.
• Avoid in known hypersensitivity to meloxicam or other NSAIDs.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Meloxicam can alter the pharmacodynamics or pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased risk of bleeding.
• Other NSAIDs or COX‑2 selective inhibitors: additive gastrointestinal toxicity.
• Lithium: elevated lithium serum concentrations.

Moderate Interactions (Monitor Closely)

• SSRIs or SNRIs: heightened bleeding tendency.
• ACE inhibitors or ARBs: possible reduction in renal function.
• Diuretics: risk of electrolyte imbalance and renal impairment.
• Methotrexate: reduced clearance leading to toxicity.
• Beta‑blockers: potential attenuation of antihypertensive effect.